Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation
- 1 February 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 122 (2) , 264-273
- https://doi.org/10.1053/gast.2002.31015
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis BNew England Journal of Medicine, 1995
- PROSTAGLANDIN E PLUS FAMCICLOVIR—A NEW CONCEPT FOR THE TREATMENT OF SEVERE HEPATITIS B AFTER LIVER TRANSPLANTATION1,2Transplantation, 1994
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1988
- PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDRENThe Lancet, 1987